2022 FIT Symposium: Networking and the Job Search on Nov. 10

Save the Date! Cardiology Fellows-in-Training will have the opportunity to hear from some of Minnesota’s top cardiologists about their real-world experiences during the transition from training to practice. We will have a panel discussion for approximately 90 minutes, with time outside of that for questions and networking.

PANELISTS:

  • Catherine (Katie) Benziger, MD, MPH, FACC, FAHA – Essentia Health
  • Michelle Carlson, MD, FACC – Hennepin Healthcare
  • Selma Carlson, MD, FACC – Minneapolis VA & University of Minnesota Medical School
  • Michael Cullen, MD, FACC – Mayo Clinic
  • Andrea Elliott, MD, FACC – University of Minnesota
  • William (Bill) Katsiyiannis, MD, FACC – Minneapolis Heart Institute
  • Sheetal (Sunny) Kaul, MD, MBBS, FACC – HealthPartners
  • Carmelo Panetta, MD, FACC – University of MN Physicians
  • Retu Saxena, MD, FACC – Minneapolis Heart Institute
  • Gautam R. Shroff, MBBS, FACC – Hennepin Healthcare
  • Mengistu A. Simegn, MD, FACC, FASE – Hennepin Healthcare
  • Stephen J. Smalley, MD, FACC – Essentia Health
  • Randall (Randy) Stark, MD, FACC – Metropolitan Heart & Vascular Institute
  • Sharath S. Subramanian, MBBS, MD, FACC – Centracare Heart & Vascular Center

CME Webinar: Anemia in Patients with CVD and CKD: Current Management and Potential Role of HIF-PHIs

Program Overview:

Anemia in CKD is associated with poor CV outcomes, increased risk of CKD progression, decreased health-related quality of life (HRQOL), and increased healthcare resource utilization. Erythropoiesis-stimulating agents have been the standard of care for treating anemia in CKD but are associated with CV safety concerns; other therapies include red blood cell transfusions and iron administration, but each potentially has severe adverse events.

Hypoxia-inducible factor-prolyl hydroxylase inhibitors (HIF-PHIs) are promising novel agents in development for treating CKD-associated anemia. These oral agents increase endogenous erythropoietin production, improve iron absorption and mobilization, and decrease hepcidin production in the liver.

Anemia in Patients with CVD and CKD: Current Management and Potential Role of HIF-PHIs will provide cardiologists with information about the etiology of anemia in CKD, the effects on CV disease, HRQOL, and function, advantages and limitations of current management strategies, and the efficacy and safety data for HIF-PHIs in late-stage development for the management of CKD-related anemia.

Learning Objectives:

At the conclusion of this activity, participants should be able to:

  • Discuss the etiology of anemia in chronic kidney disease
  • Summarize how anemia affects functioning, quality of life, and health outcomes, for patients with cardiovascular disease and chronic kidney disease
  • Assess the benefits and limitations of available modalities for treating anemia in chronic kidney disease
  • Describe the mechanism of action of and efficacy and safety data for agents in late-stage development for the management of anemia of chronic kidney disease

Steering Committee:

Erin Michos, MD, MHS
Associate Professor of Medicine
Division of Cardiology
Johns Hopkins School of Medicine

Matthew Weir, MD
Professor and Chief
Division of Nephrology
Department of Medicine
University of Maryland School of Medicine

Jointly provided by USFH and Rockpointe.

This educational activity is supported by an educational grant from GlaxoSmithKline.

2022 FIT Symposium: Networking and the Job Search

Save the Date! Cardiology Fellows-in-Training will have the opportunity to hear from some of Minnesota’s top cardiologists about their real-world experiences during the transition from training to practice. We will have a panel discussion for approximately 90 minutes, with time outside of that for questions and networking.

PANELISTS:

Catherine (Katie) Benziger, MD, MPH, FACC, FAHA – Essentia Health
Michelle Carlson, MD, FACC – Hennepin Healthcare
Selma Carlson, MD, FACC – Minneapolis VA & University of Minnesota Medical School
Michael Cullen, MD, FACC – Mayo Clinic
Andrea Elliott, MD, FACC – University of Minnesota
William (Bill) Katsiyiannis, MD, FACC – Minneapolis Heart Institute
Sheetal (Sunny) Kaul, MD, MBBS, FACC – HealthPartners
Carmelo Panetta, MD, FACC – University of MN Physicians
Retu Saxena, MD, FACC – Minneapolis Heart Institute
Gautam R. Shroff, MBBS, FACC – Hennepin Healthcare
Mengistu A. Simegn, MD, FACC, FASE – Hennepin Healthcare
Stephen J. Smalley, MD, FACC – Essentia Health
Randall (Randy) Stark, MD, FACC – Metropolitan Heart & Vascular Institute
Sharath S. Subramanian, MBBS, MD, FACC – Centracare Heart & Vascular Center

Poster Contest Submissions Due Sept. 8

The 2022 Midwest Cardiovascular Forum will include a poster contest from 4:30-6:00pm on Saturday, October 29th at the Royal Sonesta Downtown Minneapolis.

  • There is Fellow, Resident, and a Medical Student tier in this contest.
  • There will be an award for first, second, and third place in each competition tier.
  • Regional representatives of the American College of Cardiology will judge all entries.
  • Submitting a Poster Abstract is free.
  • Conference Registration is free to those who have a poster accepted in the competition.
  • The deadline to submit your poster information is September 8th, 2022. The research or work submitted must be recent; June 2019-September 2022 should be the timeframe for consideration of poster work as we want to include good work that did not have an opportunity for in-person contests during the beginning of the pandemic.
1 2